Tremblay, André J <br/><br/>
Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.  [electronic resource] 

 -  Atherosclerosis  Sep 2006 
 - 203-12 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9150 
<br/><br/><label>Standard No.: </label>10.1016/j.atherosclerosis.2005.10.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Apolipoprotein A-I--blood<br/>Apolipoprotein B-100--blood<br/>Apolipoprotein B-48--blood<br/>Apolipoproteins--blood<br/>Fenofibrate--therapeutic use<br/>Heterozygote<br/>Humans<br/>Hyperlipoproteinemia Type II--complications<br/>Hyperlipoproteinemia Type III--complications<br/>Hypolipidemic Agents--therapeutic use<br/>Kinetics<br/>Male<br/>Triglycerides--blood